Q: What is Golimumab used for?

Golimumab is used to treat: rheumatoid arthritis psoriatic arthritis ankylosing spondylitis and others.

Q: How does Golimumab work?

Targeting Inflammation Golimumab belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by targeting a specific protein called TNF-alpha, which is naturally produced by the immune system. While this protein is necessary for fighting infections, having too much of it can lead to chronic inflammation and damage to healthy tissues. In conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, the immune system becomes overactive and produces excessive amounts of TNF-alpha. This excess causes the pain, swelling, and stiffness associated with these diseases. Blocking the Inflammatory Process Golimumab is designed to find and bind to TNF-alpha proteins in the blood and on cell surfaces. By latching onto these proteins, the medication prevents them from interacting with their receptors. This action effectively blocks the inflammatory signals that would otherwise lead to: Joint destruction and bone erosion Swelling and pain in the joints or spine Inflammation and sores in the lining of the colon By lowering the activity of TNF-alpha, golimumab helps to control the symptoms of autoimmune disorders and may help prevent further physical damage over time.

Q: What are the brand names for Golimumab?

Golimumab is sold under the brand names Simponi and Simponi Aria .

Q: What are the active ingredients in Golimumab?

The active ingredient in Golimumab is golimumab .

Q: What are the side effects of Golimumab?

Common side effects of Golimumab may include: upper respiratory infection injection site reactions fatigue Always consult with a healthcare professional about potential side effects.

Q: What drug class is Golimumab?

Golimumab belongs to the TNF inhibitor drug class.

Q: What is the dosage of Golimumab and how do I take it?

Administration Methods Golimumab is available in two forms: a subcutaneous injection and an intravenous (IV) infusion. Subcutaneous Injection Subcutaneous injections are typically administered once a month. Patients or caregivers may be trained to give these injections at home using a prefilled syringe or an autoinjector device. When preparing for an injection: Allow the medication to reach room temperature before use. Do not shake the syringe or autoinjector. Choose a different injection site each time, such as the front of the thighs, the abdomen (avoiding the area around the navel), or the outer upper arms. Do not inject into skin that is tender, bruised, red, hard, or scarred. Intravenous Infusion The intravenous form of golimumab is given by a healthcare professional in a medical facility. The medication is infused slowly into a vein. Following the initial doses, maintenance infusions are typically scheduled at regular intervals. Missed Doses If a dose is missed, contact a healthcare provider for instructions on when to resume treatment. Do not use extra medication to make up for a missed dose.

Q: Is Golimumab safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the safety of golimumab use in pregnant women. Research indicates that golimumab crosses the placenta and can be detected in the blood of infants born to mothers treated with the medication. This exposure may affect the infant's immune system. If golimumab is used during pregnancy, it is important to discuss the timing of infant vaccinations with a healthcare professional. Live vaccines should generally be avoided in infants for at least six months after the mother's last dose of golimumab during pregnancy, as the medication may increase the risk of infection from the vaccine. Breastfeeding It is currently unknown whether golimumab passes into human breast milk or how it might affect a nursing infant. Because many medications are excreted in breast milk and have the potential for side effects, patients should consult their healthcare provider to decide whether to continue breastfeeding or use the medication.

Question 1

What is Golimumab?

Accepted Answer

Golimumab is a biological medication known as a human monoclonal antibody. It works by targeting and blocking the action of tumor necrosis factor (TNF), a protein in the body that plays a key role in the inflammatory process.

When the immune system produces an excess of this protein, it can lead to significant inflammation. By neutralizing the activity of TNF, this medication helps to regulate the body's immune response and reduce the underlying biological activity that causes inflammation.

Question 2

What is Golimumab used for?

Accepted Answer

Golimumab is used to treat:

rheumatoid arthritis
psoriatic arthritis
ankylosing spondylitis
and others.

Question 3

How does Golimumab work?

Accepted Answer

Targeting Inflammation

Golimumab belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by targeting a specific protein called TNF-alpha, which is naturally produced by the immune system. While this protein is necessary for fighting infections, having too much of it can lead to chronic inflammation and damage to healthy tissues.

In conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, the immune system becomes overactive and produces excessive amounts of TNF-alpha. This excess causes the pain, swelling, and stiffness associated with these diseases.

Blocking the Inflammatory Process

Golimumab is designed to find and bind to TNF-alpha proteins in the blood and on cell surfaces. By latching onto these proteins, the medication prevents them from interacting with their receptors. This action effectively blocks the inflammatory signals that would otherwise lead to:

Joint destruction and bone erosion
Swelling and pain in the joints or spine
Inflammation and sores in the lining of the colon

By lowering the activity of TNF-alpha, golimumab helps to control the symptoms of autoimmune disorders and may help prevent further physical damage over time.

Question 4

What are the brand names for Golimumab?

Accepted Answer

Golimumab is sold under the brand names Simponi and Simponi Aria.

Question 5

What are the active ingredients in Golimumab?

Accepted Answer

The active ingredient in Golimumab is golimumab.

Question 6

What are the side effects of Golimumab?

Accepted Answer

Common side effects of Golimumab may include:

upper respiratory infection
injection site reactions
fatigue

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Golimumab?

Accepted Answer

Golimumab belongs to the TNF inhibitor drug class.

Question 8

What is the dosage of Golimumab and how do I take it?

Accepted Answer

Administration Methods

Golimumab is available in two forms: a subcutaneous injection and an intravenous (IV) infusion.

Subcutaneous Injection

Subcutaneous injections are typically administered once a month. Patients or caregivers may be trained to give these injections at home using a prefilled syringe or an autoinjector device. When preparing for an injection:

Allow the medication to reach room temperature before use.
Do not shake the syringe or autoinjector.
Choose a different injection site each time, such as the front of the thighs, the abdomen (avoiding the area around the navel), or the outer upper arms.
Do not inject into skin that is tender, bruised, red, hard, or scarred.

Intravenous Infusion

The intravenous form of golimumab is given by a healthcare professional in a medical facility. The medication is infused slowly into a vein. Following the initial doses, maintenance infusions are typically scheduled at regular intervals.

Missed Doses

If a dose is missed, contact a healthcare provider for instructions on when to resume treatment. Do not use extra medication to make up for a missed dose.

Question 9

Is Golimumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of golimumab use in pregnant women. Research indicates that golimumab crosses the placenta and can be detected in the blood of infants born to mothers treated with the medication. This exposure may affect the infant's immune system.

If golimumab is used during pregnancy, it is important to discuss the timing of infant vaccinations with a healthcare professional. Live vaccines should generally be avoided in infants for at least six months after the mother's last dose of golimumab during pregnancy, as the medication may increase the risk of infection from the vaccine.

Breastfeeding

It is currently unknown whether golimumab passes into human breast milk or how it might affect a nursing infant. Because many medications are excreted in breast milk and have the potential for side effects, patients should consult their healthcare provider to decide whether to continue breastfeeding or use the medication.

Question 10

What forms and strengths does Golimumab come in?

Accepted Answer

Golimumab is available for subcutaneous administration in the following delivery systems:

Prefilled Autoinjector: A single-use device designed for injection into the tissue just under the skin.
Prefilled Syringe: A single-use glass syringe with a fixed needle.

Golimumab is available as a solution for intravenous administration. This form is supplied in a single-use vial and is intended to be diluted and administered as an infusion by a healthcare provider.

Question 11

What is the FDA approval status of Golimumab?

Accepted Answer

FDA Approval Status

Golimumab was first approved by the U.S. Food and Drug Administration (FDA) in April 2009 as a subcutaneous injection. An intravenous formulation was subsequently approved in July 2013. It is classified as a tumor necrosis factor (TNF) blocker and is regulated as a biological product.

Approved Indications

The FDA has approved golimumab for the treatment of the following conditions in adults:

Moderate to severe rheumatoid arthritis (in combination with methotrexate).
Active psoriatic arthritis (alone or with methotrexate).
Active ankylosing spondylitis.
Moderate to severe ulcerative colitis in patients who are corticosteroid-dependent or have not responded to or tolerated other medications.

It is also approved for the treatment of active polyarticular juvenile idiopathic arthritis in pediatric patients 2 years of age and older.

Boxed Warning

Golimumab carries a Boxed Warning, the FDA's most serious warning level, regarding the following risks:

Serious Infections: Patients are at an increased risk for developing serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, and invasive fungal infections. Healthcare providers must test patients for latent TB before starting treatment and monitor for signs of infection during therapy.
Malignancy: Lymphoma and other malignancies, some of which have been fatal, have been reported in children and adolescent patients treated with TNF blockers.

Question 12

What should I know about Golimumab and cost?

Accepted Answer

Factors Affecting Cost

The price of golimumab is influenced by several variables, including the specific dosage required for the condition being treated and the method of administration. Because it is a biologic medication, it is generally more expensive than traditional systemic drugs.

Insurance and Medicare: Most insurance plans cover golimumab, but they often require prior authorization. Out-of-pocket costs like deductibles and co-pays will vary by plan.
Administration Method: The subcutaneous injection may have different costs compared to the intravenous infusion, which involves additional fees for the clinical visit and professional administration.
Specialty Pharmacy: This medication is usually obtained through a specialty pharmacy, which coordinates delivery and may offer specialized support services.

Financial Assistance Programs

Patients may have access to financial resources to help manage the cost of treatment:

Co-pay Savings: Manufacturers often provide co-pay cards for patients with private or commercial insurance to reduce monthly out-of-pocket expenses.
Patient Assistance: Programs may be available for patients who are uninsured or meet specific income requirements to receive the medication at a lower cost.

Golimumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Golimumab

Hospitals.net Disclosure